최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of Korean Medicine = 대한한의학회지, v.38 no.3, 2017년, pp.170 - 184
Objectives: The objective of this study was to summarize randomized clinical trials (RCTs) that have assessed efficacy and safety of mahuang and ephedrine on treatment of obesity and to propose better process of study. Methods: NLM Medline (pubmed), the Cochrane library, Scopus, Science Direct, RISS...
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
우리나라에서 비만의 유병률은 어느정도인가? | 최근 우리나라에서도 비만의 유병률이 점점 높아지고 있는 추세이다. 2014년도 국민건강영양조사에 따르면 만 19세 이상 체질량지수 25kg/m2이상인 비만인구가 1998년 26.0%에서 2001년 29.2%, 2007년 31.7%로 증가한 후 최근 7년간 31~32% 수준을 유지하고 있다2). 비만은 제 2형 당뇨병, 고혈압, 관상동맥 심혈관질환, 관절염, 간 및 담낭질환, 특정 암의 발병률을 높이며 이로 인한 사망률을 증가시킨다3,4). | |
비만이란? | 비만은 체내에 필요한 에너지보다 과다 섭취하거나 섭취된 에너지보다 적게 소비함에 따라 발생하는 에너지 불균형의 상태를 의미하며, 인체 내에 지방조직이 과다한 상태로 정의한다1). 비만의 원인은 호르몬의 변화, 유전, 정신 건강 문제, 사회경제적 요인 등이 복합적으로 관련되어 있으며, 비만이 세계보건기구 질병 코드에 포함된 것은 불과 50여 년이 지났을 뿐이지만 이미 전세계적인 문제로 발전하여 인류의 질병과 장애에 중요한 영향을 미치고 있다1). | |
비만의 원인은 무엇인가? | 비만은 체내에 필요한 에너지보다 과다 섭취하거나 섭취된 에너지보다 적게 소비함에 따라 발생하는 에너지 불균형의 상태를 의미하며, 인체 내에 지방조직이 과다한 상태로 정의한다1). 비만의 원인은 호르몬의 변화, 유전, 정신 건강 문제, 사회경제적 요인 등이 복합적으로 관련되어 있으며, 비만이 세계보건기구 질병 코드에 포함된 것은 불과 50여 년이 지났을 뿐이지만 이미 전세계적인 문제로 발전하여 인류의 질병과 장애에 중요한 영향을 미치고 있다1). |
World Health Organization. Reducing Risks-Promoting healthy life. World Health Report 2002, Geneva, WHO 2002.
Ministry of Health and Welfare. Korea Centers for Disease Control and Prevention. Korea Health Statistics 2014:Korea National Health and Nutrition Examination Survey (KNHANES VI-2).
Kopelman P. Health risks associated with overweight and obesity. Obesity Reviews. 2007;8(1):13-17.
Kopelman PG. Obesity as a medical problem. Nature. 2000;404(6778):635-643.
Lee KW. Correct Obesity Drug Therapy. Korean Journal of International Medicine. 2009;77(4):971-976.
Lee TH. Treatment of Obesity. Korean Journal of Medicine. 2001;61(3):227-233.
Song YK, Lim HH. Clinical Application of Ma Huang in the Obesity Treatment. Journal of Society of Korean Medicine for Obesity Research. 2007:7(1):1-7.
Hwang MJ, Shin HD, Song MY. Literature review of herbal medicines on treatment of obesity since 2000-Mainly about Ephedra herba. Journal of Society of Korean Medicine for Obesity Research. 2007;7(1):39-54.
Lim SY, Park SW, Joo JH, Kim SR, Kim DJ, Choi WS. The effects of Taeeumjowui-tang (Taiyintiaowei-tang) on obesity in sasang constitution. The Journal of East-West Medicine. 2012;37(4):109-116.
Professors of formula study of Korean Medicine School. Clinical Traditional Herbalogy. Seoul; Yeong-lim Press. 2016:236
Andraws R, Chawla P, Brown DL. Cardiovascular effects of ephedra alkaloids: a comprehensive review. Progress in Cardiovascular Diseases. 2005;47(4): 217-25.
Lee MK, Cheng BW, Che CT, Hsieh DP. Cytotoxicity assessment of Ma-huang (Ephedra) under different conditions of preparation. Toxicol Sci. 2000;56(2):424-30.
Jang IS, Hwang EH. The Need for Clinical Practice Guidelines in Usage of Mahuang in Weight Loss. Journal of Society of Korean Medicine for Obesity Research. 2007:(1):23-29.
Department of Health and Human Services, Agency for Healthcare Research and Quality, Shekelle P, Hardy ML, Morton SC, Maglione M, Suttorp M, et al. Ephedra and ephedrine for weight loss and athletic performance enhancement: Clinical efficacy and side effects. Available at: URL:http://www.fda.gov/OHRMS/DOCKETS/98fr/95n-0304-bkg0003-ref-07-01-index.htm. Accessed June, 2007.
Kim HJ, Han CH, Lee EJ, Song YK, Shin BC, Kim YK. A clinical practice guideline for Ma-huang(Ephedra sinica) prescription in obesity. Journal of Society of Korean Medicine for Obesity Research. 2007;7(2):27-37.
Liu AG, Smith SR, Fujioka K, Greenway FL. The effect of leptin, caffeine/ephedrine, and their combination upon visceral fat mass and weight loss. Obesity. 2013;21(10): 1991-1996.
Kim HJ, Park JM, Kim JA, Ko BP. Effect of Herbal Ephedra sinica and Evodia rutaecarpa on Body Composition and Resting Metabolic Rate: A Randomized, Double-blind Clinical Trial in Korean Premenopausal Women. Journal of Acupuncture and Meridian Studies. 2008;1(2):128-138.
Hackman RM, Havel PJ, Schwartz JH, Rutledge JC, Watnik MR, Nocite EM, et al. Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: A randomized controlled trial. International Journal of Obesity. 2006;30(10):1545-1556.
Vukovich MD, Schoorman R, Heilman C, Jacob P, Benowitz NL. Caffeine-herbal ephedra combination increases resting energy expenditure, heart rate and blood pressure. Clinical and Experimental Pharmacology and Physiology. 2005;32(1-2):47-53.
Haller CA, Jacob P, Benowitz NL. Short-term metabolic and hemodynamic effects of ephedra and guarana combinations. Clinical pharmacology and therapeutics. 2005;77(6):560-71.
McBride BF, Karapanos AK, Krudysz A, Kluger J, Coleman CI, White CM. Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial. Journal of American Medical Association. 2004;291(2):216-21.
Hioki C, Yoshimoto K, Yoshida T. Efficacy of bofu-tsusho-san, an oriental herbal medicine, in obese Japanese women with impaired glucose tolerance. Clinical and experimental pharmacology & physiology. 2004;31(9):614-9.
Haller CA, Jacob P, Benowitz NL. Enhanced stimulant and metabolic effects of combined ephedrine and caffeine. Clinical pharmacology and therapeutics. 2004;75(4):259-73.
Greenway FL, Jonge L, Blanchard D, Frisard M, Smith SR. Effect of a dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition. Obesity Research. 2004;12(7):1152-1157.
Coffey CS, Steiner D, Baker BA, Allison DB. A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment. International Journal of Obesity. 2004;28(11):1411-1419.
Kalman D, Incledon T, Gaunaurd I, Schwartz H, Krieger D. An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra-caffeine weight loss product in healthy overweight adults. International journal of obesity and related metabolic disorders. journal of the International Association for the Study of Obesity. 2002:26;363-1366.
Boozer CN, Daly PA, Homel P, Solomon JL, Blanchard D, Nasser JA, et al. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial. International journal of obesity and related metabolic disorders. journal of the International Association for the Study of Obesity. 2002;26(5), 593-604.
Zaragoza RM, Lonngi G, Ortiz RA, Huerta DR. Comparison of two formulations of d-norpseudoephedrine and placebo in obese patients treated during six months. Medicina Interna de Mexico. 2001:17(6);260-71.
Boozer CN, Nasser JA, Heymsfield SB, Wang V, Chen G, Solomon JL. An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial. International journal of obesity and related metabolic disorders. journal of the International Association for the Study of Obesity. 2001:25(3);316-24.
Molnar D, Torok K, Erhardt E, Jeges S. Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents. International journal of obesity and related metabolic disorders. journal of the International Association for the Study of Obesity. 2000:24(12);1573-8.
Kalman DS, Colker CM, Shi Q, Swain MA. Effects of a weight-loss aid in healthy overweight adults: Double-blind, placebo-controlled clinical trial. Current Therapeutic Research - Clinical and Experimental. 2000:61(4);199-205.
Jang IS, Yang CS, Hwang EH. The need for clinical practice guidelines in usage of Mahuang in weight loss. Journal of Society of Korean Medicine for Obesity Research. 2007:7(1):23-29.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.